Skip to main content
Top
Published in: Pediatric Nephrology 9/2010

01-09-2010 | Original Article

Inflammatory activation in children with primary hypertension

Authors: Mieczyslaw Litwin, Jacek Michałkiewicz, Anna Niemirska, Lidia Gockowska, Izabela Kubiszewska, Aldona Wierzbicka, Zbigniew T. Wawer, Roman Janas

Published in: Pediatric Nephrology | Issue 9/2010

Login to get access

Abstract

Low-grade inflammation plays a role in the pathogenesis of primary hypertension (PH) and target organ damage (TOD). We evaluated the profile of inflammatory mediators (CRP, RANTES, MIP-1β, MIP-1α, MCP-1, IL-6, angiogenin, adiponectin) in 30 healthy children (12.7 ± 3.3 years) and 44 patients with untreated PH (13.7 ± 2.7 years; n.s). Patients had greater concentrations of CRP, MIP-1β, and RANTES than controls (all p < 0.05). Children with metabolic syndrome (MS) had greater CRP than children without MS (p = 0.007) and CRP correlated with number of MS criteria, body mass index (BMI), visceral fat, deep subcutaneous fat assessed by magnetic resonance imaging, carotid intima-media thickness (cIMT), left ventricular mass index, and markers of oxidative stress. RANTES correlated with cholesterol, LDL cholesterol, ApoB, and ApoB/ApoA1. Angiogenin correlated with BMI, waist circumference, visceral fat, uric acid, and patients with cIMT>2SD had greater concentration of angiogenin than those with normal cIMT (p = 0.03). Adiponectin was lower in patients with cIMT>2SD than in those with normal cIMT (p = 0.02). No model explaining variability of TOD has been built. Elevated RANTES and MIP-1β and normal IL-6 and TNF-α levels indicate a vascular inflammatory process. Lack of correlation between CRP and chemokines suggests that vascular inflammation in PH precedes the systemic inflammatory changes.
Literature
1.
go back to reference Johnson RJ, Sautin YY, Oliver WJ, Roncal C, Mu W, Sanchez-Lozada G, Rodriguez-Iturbe B, Nakagawa T, Benner SA (2009) Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society? J Comp Physiol B 179:67–76CrossRefPubMed Johnson RJ, Sautin YY, Oliver WJ, Roncal C, Mu W, Sanchez-Lozada G, Rodriguez-Iturbe B, Nakagawa T, Benner SA (2009) Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society? J Comp Physiol B 179:67–76CrossRefPubMed
2.
go back to reference Assadi F (2008) Relation of left ventricular hypertrophy to microalbuminuria and C reactive protein children and adolescents with essential hypertension. Pediatr Cardiol 29:580–584CrossRefPubMed Assadi F (2008) Relation of left ventricular hypertrophy to microalbuminuria and C reactive protein children and adolescents with essential hypertension. Pediatr Cardiol 29:580–584CrossRefPubMed
3.
go back to reference Litwin M, Trelewicz J, Wawer ZT, Antoniewicz J, Wierzbicka A, Grenda R (2004) Intima-media thickness and arterial elasticity in hypertensive children: controlled study. Pediatr Nephrol 19:767–774CrossRefPubMed Litwin M, Trelewicz J, Wawer ZT, Antoniewicz J, Wierzbicka A, Grenda R (2004) Intima-media thickness and arterial elasticity in hypertensive children: controlled study. Pediatr Nephrol 19:767–774CrossRefPubMed
4.
go back to reference Flynn J, Aldermann MH (2005) Characteristics of children with primary hypertension seen at referral center. Pediatr Nephrol 20:961–966CrossRefPubMed Flynn J, Aldermann MH (2005) Characteristics of children with primary hypertension seen at referral center. Pediatr Nephrol 20:961–966CrossRefPubMed
5.
go back to reference Litwin M, Niemirska A, Sladowska J, Antoniewicz J, Daszkowska J, Wierzbicka A, Wawer ZT, Grenda R (2006) Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol 21:811–819CrossRefPubMed Litwin M, Niemirska A, Sladowska J, Antoniewicz J, Daszkowska J, Wierzbicka A, Wawer ZT, Grenda R (2006) Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension. Pediatr Nephrol 21:811–819CrossRefPubMed
6.
go back to reference National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The Fourth report on diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The Fourth report on diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRef
7.
go back to reference Jourdan C, Wuehl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenk JP, Grenda R, Mehls O, Troeger J, Schaefer F (2005) Normative values of intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 23:1707–1715CrossRefPubMed Jourdan C, Wuehl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenk JP, Grenda R, Mehls O, Troeger J, Schaefer F (2005) Normative values of intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 23:1707–1715CrossRefPubMed
8.
go back to reference De Simone G, Daniels SR, Deveraux RB, Meyer RA, Roman MJ, de Divitis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relation of height for weight. J Am Coll Cardiol 20:1251–1260CrossRefPubMed De Simone G, Daniels SR, Deveraux RB, Meyer RA, Roman MJ, de Divitis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relation of height for weight. J Am Coll Cardiol 20:1251–1260CrossRefPubMed
9.
go back to reference Zimmet P, Alberti K, Kaufmann F, Tajima N, Silink M, Arslanian S, Wong G, Bennet P, Shaw J, Caprio S, IDF Consensus Group (2007) The metabolic syndrome in children and adolescents—an IDF consensus report. Pediatr Diabetes 8:299–306CrossRefPubMed Zimmet P, Alberti K, Kaufmann F, Tajima N, Silink M, Arslanian S, Wong G, Bennet P, Shaw J, Caprio S, IDF Consensus Group (2007) The metabolic syndrome in children and adolescents—an IDF consensus report. Pediatr Diabetes 8:299–306CrossRefPubMed
10.
go back to reference Lloyd-Johns DM, Liu K, Tian L, Greenland P (2006) Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 145:35–42 Lloyd-Johns DM, Liu K, Tian L, Greenland P (2006) Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 145:35–42
11.
go back to reference Lambert M, Delvin EE, Paradis G, O’Loughlin J, Hanley JA, Levy E (2004) C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem 50:1762–1768CrossRefPubMed Lambert M, Delvin EE, Paradis G, O’Loughlin J, Hanley JA, Levy E (2004) C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem 50:1762–1768CrossRefPubMed
12.
go back to reference Ford ES (2003) C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999–2000. Circulation 108:1053–1058CrossRefPubMed Ford ES (2003) C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999–2000. Circulation 108:1053–1058CrossRefPubMed
13.
go back to reference Litwin M, Sladowska J, Antoniewicz J, Niemirska A, Wierzbicka A, Daszkowska J, Wawer Zt, Janas R, Grenda R (2007) Metabolic abnormalities, insulin resistance and metabolic syndrome in children with primary hypertension. Am J Hypertens 20:875–882CrossRefPubMed Litwin M, Sladowska J, Antoniewicz J, Niemirska A, Wierzbicka A, Daszkowska J, Wawer Zt, Janas R, Grenda R (2007) Metabolic abnormalities, insulin resistance and metabolic syndrome in children with primary hypertension. Am J Hypertens 20:875–882CrossRefPubMed
14.
go back to reference Ceriello A (2008) Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 31:181–184CrossRef Ceriello A (2008) Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 31:181–184CrossRef
15.
go back to reference Egashira K (2003) Molecular mechanisms mediating inflammation in vascular disease: special attention to monocyte chemoattractant protein-1. Hypertension 41:834–841CrossRefPubMed Egashira K (2003) Molecular mechanisms mediating inflammation in vascular disease: special attention to monocyte chemoattractant protein-1. Hypertension 41:834–841CrossRefPubMed
16.
go back to reference Rezzonico R, Imbert V, Chicheportiche R, Dayer JM (2001) Ligation of CD11b and CD11c beta (2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1 alfa (MIP-1alfa) and MIP-beta production in primary human monocytes through a pathway dependent on nuclear factor-kappa B. Blood 97:2932–2940CrossRefPubMed Rezzonico R, Imbert V, Chicheportiche R, Dayer JM (2001) Ligation of CD11b and CD11c beta (2) integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1 alfa (MIP-1alfa) and MIP-beta production in primary human monocytes through a pathway dependent on nuclear factor-kappa B. Blood 97:2932–2940CrossRefPubMed
17.
go back to reference Schober A (2008) Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 28:1950–1959CrossRefPubMed Schober A (2008) Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 28:1950–1959CrossRefPubMed
18.
go back to reference Tatara Y, Oishi M, Yamamoto K, Shiota A, Hayashi N, Iwamoto Y, Takeda M, Takagi T, Katsuya T, Ogihara T, Rakugi K (2009) Macrophage inflammatory protein-1beta induced cell adhesion with increased intracellular oxygen species. J Med Cell Cardiol 47:104–111CrossRef Tatara Y, Oishi M, Yamamoto K, Shiota A, Hayashi N, Iwamoto Y, Takeda M, Takagi T, Katsuya T, Ogihara T, Rakugi K (2009) Macrophage inflammatory protein-1beta induced cell adhesion with increased intracellular oxygen species. J Med Cell Cardiol 47:104–111CrossRef
19.
go back to reference Parisis JT, Koroveisis S, Giazitzouglou E, Kalivas P, Katristis D (2002) Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlation with plasma endothelin 1. Int J Cardiol 83:13–21CrossRef Parisis JT, Koroveisis S, Giazitzouglou E, Kalivas P, Katristis D (2002) Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlation with plasma endothelin 1. Int J Cardiol 83:13–21CrossRef
20.
go back to reference Veilard NR, Steffens S, Burger F, Pelli G, Mach F (2004) Differential expression patterns of proinflammatory and anti-inflammatory mediators during atherogenesis in mice. Arteriocler Thromb Vasc Biol 24:2339–2344CrossRef Veilard NR, Steffens S, Burger F, Pelli G, Mach F (2004) Differential expression patterns of proinflammatory and anti-inflammatory mediators during atherogenesis in mice. Arteriocler Thromb Vasc Biol 24:2339–2344CrossRef
21.
go back to reference Holven KB, Damas JK, Yndestadt A, Waere T, Ueland T, Halvorsen B, Hegelund B, Sandberg WJ, Semb AG, Frǿland SS, Ose L, Nenseter MS, Aukrust P (2006) Chemokines in children with familial hypercholesterolemia: selective upregulation of RANTES. Arterioscler Thromb Vasc Biol 26:200–205CrossRefPubMed Holven KB, Damas JK, Yndestadt A, Waere T, Ueland T, Halvorsen B, Hegelund B, Sandberg WJ, Semb AG, Frǿland SS, Ose L, Nenseter MS, Aukrust P (2006) Chemokines in children with familial hypercholesterolemia: selective upregulation of RANTES. Arterioscler Thromb Vasc Biol 26:200–205CrossRefPubMed
22.
go back to reference Hooper LV, Stappenbeck TS, Hong CV, Gordon JL (2003) Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 4:269–273CrossRefPubMed Hooper LV, Stappenbeck TS, Hong CV, Gordon JL (2003) Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 4:269–273CrossRefPubMed
23.
go back to reference Dai Q, Xu M, Yao M, Sun B (2007) Angiotensin AT1 receptor antagonists exert anti-inflammatory effect in spontaneous hypertensive rats. Br J Pharmacol 152:1042–1048CrossRefPubMed Dai Q, Xu M, Yao M, Sun B (2007) Angiotensin AT1 receptor antagonists exert anti-inflammatory effect in spontaneous hypertensive rats. Br J Pharmacol 152:1042–1048CrossRefPubMed
Metadata
Title
Inflammatory activation in children with primary hypertension
Authors
Mieczyslaw Litwin
Jacek Michałkiewicz
Anna Niemirska
Lidia Gockowska
Izabela Kubiszewska
Aldona Wierzbicka
Zbigniew T. Wawer
Roman Janas
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 9/2010
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-010-1548-4

Other articles of this Issue 9/2010

Pediatric Nephrology 9/2010 Go to the issue